Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Charles P. Vega, MD
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Ahmed Z. Obeidat, MD, PhD
Fluid Biomarkers: Revolutionizing MS Diagnosis
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Imaging Biomarkers: MS Progression in Focus
High-Efficacy DMTs: Transforming MS Care
Long-Term Safety of DMTs: What We Know and What We Need to Know
From Pathology to Practice: The Role of Inflammation in MS Pathology
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Michael Erdman, PharmD, BCCCP
Ali A. Habib, MD
Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?
Logan Schneider, MD
Expert Consensus on How Oxybates Influence Cardiovascular Risk in Narcolepsy Patients
Kevin Trice, MD
Lee Surkin, MD, FACC, FCCP, FASNC, FAASM
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.